Val-Cit-PAB-DEA-Dxd
Val-Cit-PAB-DEA-Dxd (compound 81) is a cleavable drug-linker conjugate designed for constructing antibody-drug conjugates (ADCs) . It incorporates the topoisomerase I inhibitor Dxd, enabling targeted cytotoxicity. This reagent is widely used in ADC research and development for both in vitro and in vivo preclinical studies.
Product Specifications
CAS Number
2964543-53-9
Field of Research
Signal Transduction
Smiles
N (C (COC (N (CCN (C (OCC1=CC=C (NC ([C@@H] (NC ([C@H] (C (C) C) N) =O) CCCNC (N) =O) =O) C=C1) =O) C) C) =O) =O) [C@@H]2C3=C4C (C=5N (C4) C (=O) C6=C (C5) [C@] (CC) (O) C (=O) OC6) =NC=7C3=C (CC2) C (C) =C (F) C7
Molecular Formula
C50H61FN10O12
Molecular Weight
1013.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4471003 1.0 µg DNA
Bpnt1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
028127 96 Tests
Solute Carrier Family 26, Member 4 (SLC26A4) BioAssayTM ELISA Kit (Human)
Sign In for Pricing
View Details